White House kills rebate rule aimed at lowering drug prices
Thursday, 11 July 2019 (
1 week ago)
Trump administration has withdrawn a rule that it had said would lower drug prices by ending the system of prescription drug after-market discounts called rebates that drugmakers pay to pharmacy benefit managers.
You Might Like
Recent related videos from verified sources
AstraZeneca Talks Drug Pricing, Pipeline, and Path Ahead
The pharmaceutical industry is firmly focused on a few key factors as of late: drug prices, M&A action, and the promise of drug pipelines. AstraZeneca , a UK-based manufacturer of numerous popular..
Credit: The Street Duration: 05:08 Published 1 week ago
AstraZeneca Biopharma President Talks Drug Rebates, Pricing
The government's decision to drop its plan to cut drug rebates from government drug plans could be a negative factor for pharma, according to AstraZeneca Biopharmaceuticals President Ruud Dobber. The..
Credit: The Street Duration: 00:47 Published 1 week ago
Recent related news from verified sources
White House scraps a proposal to lower U.S. drug prices The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy that... Reuters 1 week ago
Trump Admin Rule About Drug Prices In TV Ads Could End Up In The Hands Of Congress. Sen Joni Ernst Says She’s Ready To Help Critics of the Trump administration’s beleaguered rule demanding drug companies include prices in television ads say it was designed to fail, but Republican... Daily Caller 1 week ago
Report: White House Kills Plan for Drug Rebate Rule The Trump administration has backed away from a key part of its plan to lower drug prices, Axios is reporting. Newsmax 1 week ago White House withdraws controversial rule to eliminate drug rebates The White House is withdrawing a controversial proposal to change how drugs are paid for, a spokesman said Thursday. The administration is scrapping a rule that... WorldNews 1 week ago Also reported by • Reuters Other recent news in US